The long-term objective of the investigation proposed here is the characterization of the mechanisms regulating the structure of myotendinous junctions (MTJs). MTJs are structurally and functionally specialized sites for transmission of force between muscle and tendon and for addition and deletion of sarcomeres during muscle growth and remodeling. MTJs are also primary sites of injury during eccentric contractions and exhibit early defects in Duchenne muscular dystrophy. Notwithstanding the fundamental physiological importance of MTJs in muscle growth, force transmission, muscle injury and disease, there are no published findings concerning mechanisms regulating the structure of MTJs. Substantial preliminary findings implicate the following hypothetical mechanism for regulating MTJ structure growth, repair and remodeling. Hypothesis: Perturbations of muscle (including modified use, injury or growth) stimulate macrophages at MTJs to secrete interleukin-1Beta (IL-1Beta). IL-1Beta then stimulates macrophages and fibroblasts at the MTJ to secrete platelet derived growth factor (PDGF). PDGF binds to PDGF-receptors concentrated at MTJs. PDGF-receptors autophosphorylate on tyrosine and also phosphorylate tyrosine on some or all of the following proteins involved in linking thin filaments to the muscle cell membrane at MTJs: talin, vinculin, paxillin and integrin Beta1. Phosphorylation of PDGF-receptor causes internalization and degradation of the receptor-ligand complex, thereby providing a negative control for the PDGF-mediated process. Phosphorylation of MTJ structural proteins(s) results in dissociation of myofibrils from the MTJ membrane. PDGF binding also results in activation of proteases, called calpains, that are concentrated at the MTJ. Calpains then act on their substrates at the MTJ, talin and vinculin, thereby contributing to dissociation of myofibrils from the membrane. PDGF-receptors are also substrates for calpain, providing another negative feedback mechanism for the PDGF- stimulated process. Finally, PDGF binding by muscle stimulates type IV collagenase release from the muscle, thereby degrading extracellular components of the MTJ to enable growth or remodeling. The hypothetical mechanism will be tested using hindlimb-suspended rat muscle that undergoes MTJ remodeling during reloading following suspension. The mechanism also will be examined in L6 rat myoblast using in vitro manipulations. The remodeling process will be examined using biochemical, immunological, morphological and biomechanical assays.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR040343-05
Application #
2079995
Study Section
Respiratory and Applied Physiology Study Section (RAP)
Project Start
1989-08-05
Project End
1997-03-31
Budget Start
1994-04-01
Budget End
1995-03-31
Support Year
5
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Miscellaneous
Type
Schools of Arts and Sciences
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Curzi, D; Lattanzi, D; Ciuffoli, S et al. (2013) Growth hormone plus resistance exercise attenuate structural changes in rat myotendinous junctions resulting from chronic unloading. Eur J Histochem 57:e37
Wehling-Henricks, Michelle; Tidball, James G (2011) Neuronal nitric oxide synthase-rescue of dystrophin/utrophin double knockout mice does not require nNOS localization to the cell membrane. PLoS One 6:e25071
Villalta, S Armando; Rinaldi, Chiara; Deng, Bo et al. (2011) Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype. Hum Mol Genet 20:790-805
Wehling-Henricks, Michelle; Jordan, Maria C; Gotoh, Tomomi et al. (2010) Arginine metabolism by macrophages promotes cardiac and muscle fibrosis in mdx muscular dystrophy. PLoS One 5:e10763
Villalta, S Armando; Nguyen, Hal X; Deng, Bo et al. (2009) Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Hum Mol Genet 18:482-96
Wehling-Henricks, Michelle; Oltmann, Meredith; Rinaldi, Chiara et al. (2009) Loss of positive allosteric interactions between neuronal nitric oxide synthase and phosphofructokinase contributes to defects in glycolysis and increased fatigability in muscular dystrophy. Hum Mol Genet 18:3439-51
Wehling-Henricks, Michelle; Sokolow, Sophie; Lee, Jamie J et al. (2008) Major basic protein-1 promotes fibrosis of dystrophic muscle and attenuates the cellular immune response in muscular dystrophy. Hum Mol Genet 17:2280-92
Tidball, James G; Wehling-Henricks, Michelle (2005) Damage and inflammation in muscular dystrophy: potential implications and relationships with autoimmune myositis. Curr Opin Rheumatol 17:707-13
Wehling-Henricks, Michelle; Jordan, Maria C; Roos, Kenneth P et al. (2005) Cardiomyopathy in dystrophin-deficient hearts is prevented by expression of a neuronal nitric oxide synthase transgene in the myocardium. Hum Mol Genet 14:1921-33
Tidball, James G; Wehling-Henricks, Michelle (2004) Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins. Mol Genet Metab 82:312-20

Showing the most recent 10 out of 51 publications